To the best of our knowledge, this is the first demonstration that dual targeting of redox APE1 and STAT3 in breast cancer is a more effective strategy than single inhibitors for reducing cell survival and proliferation, inducing cell death, and reducing cell aggressiveness through the decrease in cell migration and invasion. Here, STAT3 is linked to breast cancer.